Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

While I did a cut and paste of the relevant FDA document, given your nom de plume, you might want to peruse the entire document...

http://blogs.fda.gov/fdavoice/index.php/tag/priority-review/

There is a 2015 document but they did not address the same issues. However, we know the FDA is pressing to improve their processes even absent the issues on opioid abuse. I am no medical expert, my knowledge lies in business strategy. However, the events in the external environment are critical to understanding and assessing the opportunities a firm may have. So it is that I pay attention to the threats (all part of a simple SWOT).